Amazon’s profitability highlights success in growth sources. Vertex Pharmaceuticals launches new products, more approvals expected. TJX Companies a resilient winner in retail. Growth stocks fluctuate in favor with investors. Amazon boasts strong returns, with AWS a primary profit engine. Advertising is fastest-growing segment for Amazon, expected to exceed $60 billion in 2025. AI investments and robotics in warehouses aim to boost Amazon’s efficiency and profitability. Vertex Pharmaceuticals sees success with diverse portfolio and new products. Vertex reports revenue surpassing $3 billion in Q3 2025. TJX Companies outperforms in retail, beats earnings and revenue expectations. TJX has a unique off-price model that attracts wide range of consumers. TJX’s unpredictability in inventory creates an adventurous shopping experience. TJX’s fiscal Q3 2026 results exceed Wall Street’s expectations. TJX pays a dividend and has raised it for almost three decades. Rachel Warren has positions in Amazon, The Motley Fool has positions in and recommends Amazon, CRISPR Therapeutics, Nvidia, TJX Companies, and Vertex Pharmaceuticals.

Read more at Yahoo Finance: 3 Supercharged Growth Stocks to Buy and Hold Into the 2030s